Similar articles

• The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type.

  Stadelmeyer E, Heitzer E, Resel M, Cerroni L, Wolf P, Dandachi N. Stadelmeyer E, et al. J Invest Dermatol. 2014 Feb;134(2):548-550. doi: 10.1038/jid.2013.338. Epub 2013 Aug 9. J Invest Dermatol. 2014. PMID: 24026210 No abstract available.
• Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes.

  Lang J, MacKie RM. Lang J, et al. J Invest Dermatol. 2005 Sep;125(3):575-9. doi: 10.1111/j.0022-202X.2005.23833.x. J Invest Dermatol. 2005. PMID: 16117801
• Braf-V600e immunohistochemical analyses in a series of 15, Caucasian patients affected by lentigo maligna.

  Dika E, Lambertini M, Fanti PA, Scarfì F, Corti B, Altimari A, Ceccarelli C, Pesci S, Evangelista V, Patrizi A. Dika E, et al. Acta Histochem. 2019 Apr;121(3):380-381. doi: 10.1016/j.acthis.2019.02.003. Epub 2019 Feb 20. Acta Histochem. 2019. PMID: 30797564 No abstract available.
• Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.

  Huss S, Pasternack H, Ihle MA, Merkelbach-Bruse S, Heitkötter B, Hartmann W, Trautmann M, Gevensleben H, Büttner R, Schildhaus HU, Wardelmann E. Huss S, et al. Hum Pathol. 2017 Apr;62:206-214. doi: 10.1016/j.humpath.2017.01.005. Epub 2017 Feb 1. Hum Pathol. 2017. PMID: 28159677 Review.
• Lentigo Maligna.

  Franke JD, Woolford KM, Neumeister MW. Franke JD, et al. Clin Plast Surg. 2021 Oct;48(4):669-675. doi: 10.1016/j.cps.2021.06.007. Epub 2021 Aug 5. Clin Plast Surg. 2021. PMID: 34503727 Review.